(Press-News.org) SAN DIEGO – (December 9, 2010) – A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab® Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
The findings, which also showed the platform's ability to predict critical type 1 diabetes molecular "biomarkers," were published in the December issue of the scientific journal Diabetes, and further validate the importance of the new model as a valuable research tool in type 1 diabetes. The software is designed to enable researchers to rapidly streamline laboratory research through the evaluation of alternative scenarios for therapeutic strategies that show the most promise for working in humans.
"Since laboratory studies can cost hundreds of thousands of dollars, and early stage human clinical trials can cost $10 million dollars or more, predicting the right conditions to try is important," said Dr. von Herrath, director of the Type 1 Diabetes Research Center at the La Jolla Institute for Allergy & Immunology, where the studies were conducted.
"We've found that using this in silico (computer analysis) prediction platform can quicken the pace and effectiveness of type 1 diabetes research," he continued. "By allowing us to pre-test our theories in computer models, we can ensure that the more time-intensive and costly process of laboratory testing is focused on the most promising therapeutic strategies, with the greatest chance of success."
The platform, developed by Entelos Inc., a life sciences company specializing in predictive technologies, has previously been shown to successfully predict various data from published type 1 diabetes experiments. Dr. von Herrath's team used a different approach to test the model, asking it to predict the outcome of a hypothetical experiment on nasal insulin dosing frequency in animal models that had not yet been performed. The prediction was then tested in the laboratory, where its results were confirmed.
In addition, he said, the model was able to accurately identify the particular time frame at which key type 1 diabetes "biomarkers" kicked in. Biomarkers are specific cell types or proteins that tell researchers at what point a therapeutic option is working or when it is time to start treatment. In the case of the La Jolla Institute study, the model successfully predicted the onset of biomarkers indicating beta cell protection in the NOD mouse.
"The model accurately predicted that implementing a low frequency nasal insulin dosing regimen in animal models was more beneficial in controlling type 1 diabetes than a high frequency regimen," said Dr. von Herrath, noting that the software's prediction of the biomarkers was key in this process. "These results confirmed our hypotheses on the benefits of low-frequency nasal insulin dosing. But even more importantly, the advantage of applying computer modeling in optimizing the therapeutic efficacy of nasal insulin immunotherapy was confirmed."
The results were reported in the paper "Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency To Be Crucial for Diabetes Protection." Dr. von Herrath was senior author on the paper and La Jolla Institute scientist Georgia Fousteri, Ph.D., and Jason Chan, Ph.D., from Entelos' R&D group, were first co-authors.
The Type 1 Diabetes PhysioLab® Platform is a large-scale mathematical model of disease pathogenesis based on non-obese diabetic (NOD) mice. The platform was developed with input from an independent scientific team of leading type 1 diabetes experts. The research support group of the American Diabetes Association funded the work of the software's development to provide a new scientific tool for enhancing the speed and effectiveness of type 1 diabetes research.
More than 400,000 children worldwide suffer from type 1 diabetes, a chronic disease that can lead to severe complications, such as blindness, cardiovascular disease, renal disease, coma or even death.
The platform, developed over two years, simulates autoimmune processes and subsequent destruction of pancreatic beta cells from birth through frank diabetes onset (hyperglycemia). The destruction of insulin-producing beta cells in the pancreas is the underlying cause of type 1 diabetes.
Specifically, Dr. von Herrath's team employed the model to investigate the possible mechanisms underlying the effectiveness of nasal insulin therapy, using the B: 9-23 peptide. "The experimental aim was to evaluate the impact of dose, frequency of administration and age at treatment on key molecular mechanisms and optimal therapeutic outcome," he said.
Using parameters input by the scientific team, the model accurately predicted that less frequent doses of nasal insulin, started at an early disease stage, would protect more effectively against beta cell destruction than higher frequency doses in NOD mice.
Dr. von Herrath added that the positive results add credence to the idea of creating computer models for analyzing therapeutic interventions in human disease. "These results support the development and application of humanized platforms for the design of clinical trials," he said.
###
About La Jolla Institute
Founded in 1988, the La Jolla Institute for Allergy & Immunology is a biomedical research nonprofit focused on improving human health through increased understanding of the immune system. Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma. La Jolla Institute's research staff includes more than 100 Ph.D.s and M.D.s. For more information, go to www.liai.org
END
States, not the federal government, now fund the majority of human embryonic stem cell research conducted in the United States, according to a recent study in the journal Nature Biotechnology. In addition, states varied substantially in the extent to which they prioritized human embryonic stem cell research, and much of the research performed in the states could likely have been funded by the National Institutes of Health under federal guidelines established by President Bush in 2001.
"While the federal government still contributes more to stem cell research overall, ...
It goes without saying that conservatives and liberals don't see the world in the same way. Now, research from the University of Nebraska-Lincoln suggests that is exactly, and quite literally, the case.
In a new study, UNL researchers measured both liberals' and conservatives' reaction to "gaze cues" – a person's tendency to shift attention in a direction consistent with another person's eye movements, even if it's irrelevant to their current task – and found big differences between the two groups.
Liberals responded strongly to the prompts, consistently moving their ...
The Fix is the story of Eddie Parker, a con man on the run who is looking for his identity, although he doesn't know it. Eddie comes to America in 1949 from Bergen Belsen, a German displacement camp, at the age of eight. He lands on the streets of New York with his family and he quickly learns the rules of the street. He convinces his son, a high school star basketball player, to fix games for the mob. When the plan goes horribly wrong, Eddie is on the run, taking an adventure to save his life.
Mr. Shaw is best known for his most recent work in 2001, the Broadway production ...
Murphy, Pearson, Bradley & Feeney, P.C. announces the elevations of San Francisco attorneys Thomas "Tip" Mazzucco, Thomas D'Amato and Janet Everson to shareholders, effective Jan. 1. The elevations bring the total number of firmwide shareholders to 14.
"We are excited to be elevating one of the largest shareholder classes in firm history. Tom, Janet and Tip are superb trial lawyers and have played an integral role in our firm's continued success," said Michael Bradley, managing director of Murphy, Pearson, Bradley & Feeney. "Their litigation expertise, industry knowledge ...
In a time when young couples are trying to make the most out of their wedding day and the budget is more limited than ever, strapped fiances are finding themselves dancing from the alter to the reception floor. Today's brides are finding creative ways to spice up their wedding day, and salsa dancing has just the right amount of heat.
COSTA MESA, CA, DECEMBER 8, 2010 - Hunting for ways to make their wedding reception both entertaining and affordable, couples have been turning back to the pages of tradition in droves. This holiday season, a record number of brides and ...
As a world-renowned relationship expert and wife and mother of 25 years, Dr. Patty Ann Tublin knows people can do a lot while under stress. But being in the mood for sex and feeling sexy, is not one of them. She talks about five stressors that could be zapping your libido in a new article on her web site. "Stress and Sex: 5 Stressors That Can Put Your Libido on Hold," is available now at http://bit.ly/epkmvr
According to Dr. Patty Ann, stress is pretty high up there as one of the top reasons for why couples are not having sex. The article discusses common stressors that ...
You love entertaining guests at the holidays - celebrating with old friends and relatives and clinking glasses around a big feast. But what if one of your guests can't eat gluten? Whether your guest is Celiac, has a food allergy or is trying a detox diet, here are five easy tips to take the stress out of entertaining them for the holidays:
1. Ask first, ask early. When you're inviting guests, be sure to ask them right away if they have any dietary restrictions. The earlier you ask, the more time you'll have to prepare, and the more time your guest will have to help you ...
EECPA is an established accounting firm, which is owned and operated by Elizabeth Hale in Phoenix, Arizona. Elizabeth has twenty years of accounting experience. She attained her accounting degree in 1993, at St. John Fisher College in Rochester, New York.
EECPA is more than happy to assist you in any way possible. Being a small firm, EECPA PLC, will still give you and your business knowledge of a big accounting firm, but they do it with a small firm friendliness and atmosphere. They will acknowledge you and your associates by name.
Some of these services include; ...
We get pressure to buy, buy, buy - as if that is the only way to really show someone else how much we care. That being said, and in the holiday spirit, here are 10 really great (but not so usual) gift ideas for the people you love. Maybe they will inspire you to think differently about gift-giving.
ONE - Give the gift of a weekly uninterrupted, non-distracted phone call. No multi-tasking. No talking and driving. Be really present. Listen. Share.
TWO - Give the gift of getting fit together. Commit to walking together, going to the gym, riding bikes or other fitness method. ...
FashiONLINE's It's All About the Look provided teens and tweens with education on not only how to style themselves, but how to dress properly at work. "More than ever, there is a dress code ambiguity in the workplace and it is vital that teens/tweens as well as young professionals learn what is considered appropriate and what is crossing the line." says co-director of FashionCampNYC, Fran Della Badia.
It doesn't matter what one looks like on Facebook or Twitter, but how one presents herself in the real world that matters. FashiONLINE It's All About the Look, left viewers ...
